Literature DB >> 31189758

Regulation of growth hormone biosynthesis by Cdk5 regulatory subunit associated protein 1-like 1 (CDKAL1) in pituitary adenomas.

Yoshihiro Takesue1,2, Fan-Yan Wei1, Hiroyuki Fukuda1, Yuki Tanoue3, Takahiro Yamamoto1,2, Takeshi Chujo1, Naoki Shinojima2, Shigetoshi Yano2,4, Motohiro Morioka5, Akitake Mukasa2, Junichi Kuratsu2,6, Kazuhito Tomizawa1,7.   

Abstract

CDK5 regulatory subunit associated protein 1-like 1 (CDKAL1) is a tRNA-modifying enzyme that catalyzes 2-methylthiolation (ms2) and has been implicated in the development of type 2 diabetes (T2D). CDKAL1-mediated ms2 is important for efficient protein translation and regulates insulin biosynthesis in pancreatic cells. Interestingly, an association between T2D and release of growth hormone (GH) has been reported in humans. However, it is unknown whether CDKAL1 is important for hormone production in the pituitary gland. The present study investigated the role of CDKAL1 in GH-producing pituitary adenomas (GHPAs). CDKAL1 activity was suppressed in GHPAs, as evidenced by a decrease in ms2, compared with non-functioning pituitary adenomas (NFPAs), which do not produce specific hormones. Downregulation of Cdkal1 using small interfering and short hairpin RNAs increased the biosynthesis and secretion of GH in rat GH3 cells. Depletion of Cdkal1 increased the cytosolic calcium level via downregulation of DnaJ heat shock protein family (Hsp40) member C10 (Dnajc10), which is an endoplasmic reticulum protein related to calcium homeostasis. This stimulated transcription of GH via upregulation of Pit-1. Moreover, CDKAL1 activity was highly sensitive to proteostatic stress and was upregulated by suppression of this stress. Taken together, these results suggest that dysregulation of CDKAL1 is involved in the pathogenesis of GHPAs, and that modulation of the proteostatic stress response might control CDKAL1 activity and facilitate treatment of GHPAs.

Entities:  

Keywords:  Growth hormone; Hypophyseal tumor; Pituitary tumor; Protein synthesis; tRNA

Mesh:

Substances:

Year:  2019        PMID: 31189758     DOI: 10.1507/endocrj.EJ18-0536

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  6 in total

1.  Extracellular N 6 -isopentenyladenosine (i6A) addition induces cotranscriptional i6A incorporation into ribosomal RNAs.

Authors:  Maya Yakita; Takeshi Chujo; Fan-Yan Wei; Mayumi Hirayama; Koji Kato; Nozomu Takahashi; Kenta Naganuma; Masashi Nagata; Kenta Kawahara; Hideki Nakayama; Kazuhito Tomizawa
Journal:  RNA       Date:  2022-04-12       Impact factor: 5.636

Review 2.  S-adenosylmethionine tRNA modification: unexpected/unsuspected implications of former/new players.

Authors:  Raffaella Adami; Daniele Bottai
Journal:  Int J Biol Sci       Date:  2020-09-30       Impact factor: 6.580

3.  Cooperative methylation of human tRNA3Lys at positions A58 and U54 drives the early and late steps of HIV-1 replication.

Authors:  Hiroyuki Fukuda; Takeshi Chujo; Fan-Yan Wei; Sheng-Lan Shi; Mayumi Hirayama; Taku Kaitsuka; Takahiro Yamamoto; Hiroyuki Oshiumi; Kazuhito Tomizawa
Journal:  Nucleic Acids Res       Date:  2021-11-18       Impact factor: 16.971

4.  Genome-Wide Association Study of Body Conformation Traits by Whole Genome Sequencing in Dazu Black Goats.

Authors:  Bowen Gu; Ruifan Sun; Xingqiang Fang; Jipan Zhang; Zhongquan Zhao; Deli Huang; Yuanping Zhao; Yongju Zhao
Journal:  Animals (Basel)       Date:  2022-02-23       Impact factor: 2.752

5.  Irp2 regulates insulin production through iron-mediated Cdkal1-catalyzed tRNA modification.

Authors:  Maria C Ferreira Dos Santos; Cole P Anderson; Susanne Neschen; Kimberly B Zumbrennen-Bullough; Steven J Romney; Melanie Kahle-Stephan; Birgit Rathkolb; Valerie Gailus-Durner; Helmut Fuchs; Eckhard Wolf; Jan Rozman; Martin Hrabe de Angelis; Weiling Maggie Cai; Malini Rajan; Jennifer Hu; Peter C Dedon; Elizabeth A Leibold
Journal:  Nat Commun       Date:  2020-01-15       Impact factor: 14.919

Review 6.  Human transfer RNA modopathies: diseases caused by aberrations in transfer RNA modifications.

Authors:  Takeshi Chujo; Kazuhito Tomizawa
Journal:  FEBS J       Date:  2021-02-16       Impact factor: 5.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.